e-learning
resources
Munich 2006
Monday 04.09.2006
Control of breathing
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Efficacy of intranasal corticosteroid therapy on lower respiratory tract responsiveness in children with obstructive sleep apnea syndrome
L. Brunetti, D. Rizzi, R. Tesse, R. Procacci, M. Loscialpo, M. Mastronardi, D. Locantore, O. Sillecchia, L. Armenio (Bari, Italy)
Source:
Annual Congress 2006 - Control of breathing
Session:
Control of breathing
Session type:
Thematic Poster Session
Number:
2459
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Brunetti, D. Rizzi, R. Tesse, R. Procacci, M. Loscialpo, M. Mastronardi, D. Locantore, O. Sillecchia, L. Armenio (Bari, Italy). Efficacy of intranasal corticosteroid therapy on lower respiratory tract responsiveness in children with obstructive sleep apnea syndrome. Eur Respir J 2006; 28: Suppl. 50, 2459
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Late Breaking Abstract - Efficacy of Breathox® device inhalation on acute symptoms associated with COVID-19 (BREATH study)
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
The use of systemic corticosteroids in children with obstructive sleep apnea syndrome
Source: International Congress 2019 – Evaluation of breathing in children when they are asleep, healthy or ill
Year: 2019
Are upper airways resistance syndrome and obstructive sleep apnea a side-effect of oral cancer therapy?
Source: Annual Congress 2011 - Obstructive sleep apnoea as a comorbidity
Year: 2011
Nasal continuous airway pressure therapy and respiratory infections in patients with obstructive sleep apnea
Source: Eur Respir J 2004; 24: Suppl. 48, 411s
Year: 2004
Respiratory failure in obstructive sleep apnea syndrome (OSAS)- is CPAP therapy alone adequate?
Source: Eur Respir J 2005; 26: Suppl. 49, 111s
Year: 2005
Low prevalence of obstructive sleep apnoea in paediatric severe therapy resistant asthma
Source: International Congress 2019 – Asthma education: lifestyle and adolescence
Year: 2019
Effect of nasal CPAP therapy on functional respiratory parameters and cardiopulmonary exercise test in obstructive sleep apnea syndrome
Source: Annual Congress 2012 - Physiology, obesity and the downstream effects of OSA
Year: 2012
Efficacy of continuous positive airway pressure in treatment of patients with bradyarrhythmias associated with obstructive sleep apnoea syndrome
Source: Annual Congress 2006 - Cardiovascular consequences of obstructive sleep apnoea
Year: 2006
Possibility of treating patients with obstructive sleep apnea syndrome and nocturnal asystoles using CPAP therapy
Source: Annual Congress 2009 - Clinical aspects of sleep apnoea
Year: 2009
Effect of nasal topical steroids on CPAP compliance in patients with obstructive sleep apnoea starting therapy
Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea
Year: 2007
Influence of electrostimulation of pharyngeal and laryngeal muscles with application of prolonged beta-2 agonist on functional signs of obstructive sleep apnea syndrome in patients with obstructive sleep apnea syndrome combined with chronic obstructive
Source: Eur Respir J 2003; 22: Suppl. 45, 467s
Year: 2003
Efficacy testing for oral appliance therapy in obstructive sleep apnea
Source: Virtual Congress 2021 – Advances in therapeutic plans for sleep disordered breathing
Year: 2021
Influence of electrostimulation of pharyngeal and laryngeal muscles in complex with traditional treatment of COPD on functional signs of obstructive sleep apnea syndrome in patients with combined pathology – obstructive sleep apnea syndrome + COPD
Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders
Year: 2007
Compliance with CPAP/BiPAP treatment in obstructive sleep apnea syndrome patients
Source: Annual Congress 2010 - Clinical aspects of sleep apnoea
Year: 2010
Long-term effects of nasal budesonide administered to children with mild obstructive sleep-disordered breathing
Source: Eur Respir J 2004; 24: Suppl. 48, 477s
Year: 2004
Effect of treating severe nasal obstruction on the severity of obstructive sleep apnoea
Source: Eur Respir J 2005; 25: 521-527
Year: 2005
Efficacy of continuous positive airway pressure treatment to resistant hypertension in patients with obstructive sleep apnea syndrome
Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy
Year: 2008
Particularities of clinical-functional characteristics of combination pathology - obstructive sleep apnea-hypopnea syndrome and bronchial asthma during the treatment with prolonged beta2-agonists
Source: Eur Respir J 2003; 22: Suppl. 45, 468s
Year: 2003
Effect of multiple-dose treatment with daridorexant on nighttime respiratory function in patients with mild and moderate obstructive sleep apnea (OSA)
Source: Virtual Congress 2020 – Treatment of obstructive sleep apnoea and its effects
Year: 2020
CPAP and survival in moderate-to-severe obstructive sleep apnoea syndrome and hypoxaemic COPD
Source: Eur Respir J 2010; 35: 132-137
Year: 2010
Efficacy of adaptive servo-ventilation on residual sleepiness in patients with obstructive sleep apnea syndrome
Source: Annual Congress 2008 - Outcome of adaptive servo ventilation in sleep apnoea
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept